164 related articles for article (PubMed ID: 36983664)
1. Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma.
Zhou W; Cheng Y; Li L; Zhang H; Li X; Chang R; Xiao X; Lu L; Yi B; Gao Y; Zhang C; Zhang J
J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983664
[TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance.
Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q
Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125
[TBL] [Abstract][Full Text] [Related]
3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction.
Li L; Cai Q; Wu Z; Li X; Zhou W; Lu L; Yi B; Chang R; Zhang H; Cheng Y; Zhang C; Zhang J
Sci Rep; 2023 Feb; 13(1):2455. PubMed ID: 36774446
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and personalized treatment prediction in lung adenocarcinoma: An
Ma C; Li F; He Z; Zhao S; Yang Y; Gu Z
Front Pharmacol; 2023; 14():1113808. PubMed ID: 36874011
[No Abstract] [Full Text] [Related]
7. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
Tang X; Zhou H; Liu Y
Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
[TBL] [Abstract][Full Text] [Related]
8. The characterization of tumor microenvironment infiltration and the construction of predictive index based on cuproptosis-related gene in primary lung adenocarcinoma.
Li K; Wu LL; Wang H; Cheng H; Zhuo HM; Hao Y; Liu ZY; Li CW; Qian JY; Li ZX; Xie D; Chen C
Front Oncol; 2022; 12():1011568. PubMed ID: 36505852
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in lung adenocarcinoma.
Xiaona X; Liu Q; Zhou X; Liang R; Yang S; Xu M; Zhao H; Li C; Chen Y; Xueding C
Comput Biol Med; 2023 May; 158():106831. PubMed ID: 37037146
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma.
Wu G; Hu Q; Chen H; He M; Ma H; Zhou L; Xu K; Ren H; Qi J
Front Oncol; 2023; 13():1127768. PubMed ID: 37007124
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma.
Wu M; Bao J; Lei Y; Tao S; Lin Q; Chen L; Jin Y; Ding X; Yan Y; Han P
Front Oncol; 2022; 12():935672. PubMed ID: 36338763
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma.
Wang Y; Zhang C; Ji C; Jin W; He X; Yu S; Guo R
Front Genet; 2022; 13():1006938. PubMed ID: 36313439
[No Abstract] [Full Text] [Related]
13. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
14. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma.
Zhu YP; Deng HT; Wang X; Rahat MA; Sun S; Zhang QZ
Front Pharmacol; 2023; 14():1146468. PubMed ID: 37113755
[No Abstract] [Full Text] [Related]
16. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.
Li J; Yin J; Li W; Wang H; Ni B
Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100
[TBL] [Abstract][Full Text] [Related]
17. Deep learning reveals cuproptosis features assist in predict prognosis and guide immunotherapy in lung adenocarcinoma.
Li G; Luo Q; Wang X; Zeng F; Feng G; Che G
Front Endocrinol (Lausanne); 2022; 13():970269. PubMed ID: 36060936
[TBL] [Abstract][Full Text] [Related]
18. Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma.
Sun Z; Chen X; Huang X; Wu Y; Shao L; Zhou S; Zheng Z; Lin Y; Chen S
Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511958
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.
Wang F; Lin H; Su Q; Li C
World J Surg Oncol; 2022 Sep; 20(1):275. PubMed ID: 36050740
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
Song S; Zhang M; Xie P; Wang S; Wang Y
Front Immunol; 2022; 13():978909. PubMed ID: 36341328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
